Asami Fujii 1, Yoko Mizutani 1, Yuki Hattori 1, Tomoko Takahashi 1, Hidenori Ohnishi 2, Shozo Yoshida 3, Mariko Seishima 1 , Case Rep Dermatol. 2017 May 22;9(2):13-18.
Evidencia científica
Sweet’s Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis.
After the first session of GMA therapy, all symptoms including the erythematous lesions and fever were completely resolved, and serum G-CSF level was reduced. Leukocyte count, neutrophil count, serum amyloid A protein, and CRP levels were restored within normal ranges by 2 weeks. Thus, GMA therapy can successfully treat a patient with recurrent Sweet’s syndrome, potentially related to the restoration of elevated serum G-CSF levels.
ContáctanosPara solicitar información adicional
Contáctanos